Bioprinted implant may help paralyzed people walk again
First-ever spinal cord implant to treat paralysis without risk of rejection is successfully tested on mice; human trials expected by end of 2024.
First-ever spinal cord implant to treat paralysis without risk of rejection is successfully tested on mice; human trials expected by end of 2024.
Novel enzyme treatment may reduce inflammation and scarring that prevent neuronal regeneration, Israeli researchers say.